# O-RADS MRI System on Early Detection of Ovarian Cancer

> **NCT07009743** · — · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Gynecologic Oncology Group** · enrollment: 2549 (estimated)

## Conditions studied

- Ovarian Cancer (OvCa)
- Ovarian Cancer Metastatic

## Interventions

- **DIAGNOSTIC_TEST:** MRI contrast-enhancing agents

## Key facts

- **NCT ID:** NCT07009743
- **Lead sponsor:** Shanghai Gynecologic Oncology Group
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 2549 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07009743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07009743, "O-RADS MRI System on Early Detection of Ovarian Cancer". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07009743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*